Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Income towards Parent Company: 2011-2025

Historic Income towards Parent Company for Abeona Therapeutics (ABEO) over the last 14 years, with Sep 2025 value amounting to -$35.6 million.

  • Abeona Therapeutics' Income towards Parent Company fell 17.47% to -$35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.1 million, marking a year-over-year increase of 4.84%. This contributed to the annual value of -$68.4 million for FY2024, which is 43.88% down from last year.
  • Per Abeona Therapeutics' latest filing, its Income towards Parent Company stood at -$35.6 million for Q3 2025, which was down 195.60% from -$12.0 million recorded in Q2 2025.
  • Over the past 5 years, Abeona Therapeutics' Income towards Parent Company peaked at -$8.2 million during Q2 2022, and registered a low of -$46.7 million during Q4 2021.
  • Over the past 3 years, Abeona Therapeutics' median Income towards Parent Company value was -$15.3 million (recorded in 2024), while the average stood at -$19.2 million.
  • In the last 5 years, Abeona Therapeutics' Income towards Parent Company spiked by 71.90% in 2022 and then crashed by 196.31% in 2024.
  • Over the past 5 years, Abeona Therapeutics' Income towards Parent Company (Quarterly) stood at -$46.7 million in 2021, then spiked by 71.90% to -$13.1 million in 2022, then decreased by 1.56% to -$13.3 million in 2023, then slumped by 33.31% to -$17.8 million in 2024, then fell by 17.47% to -$35.6 million in 2025.
  • Its Income towards Parent Company was -$35.6 million in Q3 2025, compared to -$12.0 million in Q2 2025 and -$20.7 million in Q1 2025.